• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨重塑的生化标志物

Biochemical markers of bone remodeling.

作者信息

Seibel Markus J

机构信息

Department of Medicine, The University of Sydney, Sydney, NSW 2139, Australia.

出版信息

Endocrinol Metab Clin North Am. 2003 Mar;32(1):83-113, vi-vii. doi: 10.1016/s0889-8529(02)00077-4.

DOI:10.1016/s0889-8529(02)00077-4
PMID:12699294
Abstract

Because of the aging population in most countries, disorders of bone and mineral metabolism are becoming increasingly relevant to everyday clinical practice. Consequently, the interest in, and the need for effective measures to be used in the screening, diagnosis, and follow-up of such pathologies has markedly grown. Together with clinical and imaging techniques, laboratory tests play an important role in the assessment and differential diagnosis of metabolic bone disease.

摘要

由于大多数国家的人口老龄化,骨与矿物质代谢紊乱在日常临床实践中变得越来越重要。因此,对于用于此类病症筛查、诊断和随访的有效措施的关注和需求显著增加。与临床和成像技术一起,实验室检测在代谢性骨病的评估和鉴别诊断中发挥着重要作用。

相似文献

1
Biochemical markers of bone remodeling.骨重塑的生化标志物
Endocrinol Metab Clin North Am. 2003 Mar;32(1):83-113, vi-vii. doi: 10.1016/s0889-8529(02)00077-4.
2
Clinical application of biochemical markers of bone turnover.骨转换生化标志物的临床应用
Arq Bras Endocrinol Metabol. 2006 Aug;50(4):603-20. doi: 10.1590/s0004-27302006000400006.
3
Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis.骨转换的生化标志物 第二部分:在骨质疏松症管理中的临床应用
Clin Biochem Rev. 2006 Aug;27(3):123-38.
4
Selected markers of bone biochemistry.骨生物化学的选定标志物。
Adv Clin Chem. 2000;35:255-94. doi: 10.1016/s0065-2423(01)35018-7.
5
Biochemical markers of bone turnover: part I: biochemistry and variability.骨转换的生化标志物:第一部分:生物化学与变异性
Clin Biochem Rev. 2005 Nov;26(4):97-122.
6
Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.骨质疏松症和转移性骨病药物临床研发中骨转换的生化标志物:潜在用途与陷阱
Drugs. 2006;66(16):2031-58. doi: 10.2165/00003495-200666160-00001.
7
Clinical use of biochemical markers of bone remodeling in osteoporosis.
Bone. 1992;13 Suppl 1:S17-21. doi: 10.1016/s8756-3282(09)80005-7.
8
Clinical utility of bone markers in various diseases.骨标志物在各种疾病中的临床应用。
Bone. 2018 Sep;114:215-225. doi: 10.1016/j.bone.2018.06.011. Epub 2018 Jun 18.
9
Diagnostic imaging and biochemical markers of bone turnover.骨转换的诊断成像与生化标志物
Nurs Clin North Am. 2001 Sep;36(3):409-16, viii.
10
[Biochemical markers of bone remodeling].[骨重塑的生化标志物]
Gynecol Obstet Fertil. 2005 Dec;33(12):1009-13. doi: 10.1016/j.gyobfe.2005.10.017. Epub 2005 Nov 28.

引用本文的文献

1
Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review.膳食植物雌激素对人类整个生命周期激素的影响:综述。
Nutrients. 2020 Aug 15;12(8):2456. doi: 10.3390/nu12082456.
2
Ovariectomized rat model of osteoporosis: a practical guide.去卵巢大鼠骨质疏松模型:实用指南。
EXCLI J. 2020 Jan 10;19:89-107. doi: 10.17179/excli2019-1990. eCollection 2020.
3
Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients.循环未羧化骨钙素作为代谢综合征患者心血管和 2 型糖尿病风险的估算指标。
Sci Rep. 2020 Feb 4;10(1):1840. doi: 10.1038/s41598-020-58760-7.
4
Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis.炎症作为沙特绝经后骨质疏松女性的一个促成因素。
Medicine (Baltimore). 2017 Jan;96(4):e5780. doi: 10.1097/MD.0000000000005780.
5
Adverse bone health among children and adolescents growing up with HIV.HIV 感染者儿童和青少年的骨骼健康不良。
J Virus Erad. 2015 Jul 1;1(3):159-67. doi: 10.1016/S2055-6640(20)30506-9.
6
Cathepsin K in treatment monitoring following intravenous zoledronic acid.静脉注射唑来膦酸后组织蛋白酶K在治疗监测中的作用
Biomed Rep. 2014 Nov;2(6):915-917. doi: 10.3892/br.2014.360. Epub 2014 Sep 10.
7
The effect of metyrosine/prednisolone combination to oophorectomy-induced osteoporosis.甲酪氨酸/泼尼松龙联合用药对卵巢切除术所致骨质疏松症的影响。
Iran J Reprod Med. 2012 Jul;10(4):363-72.
8
Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study.早期多发性硬化症和普遍骨量不足患者的骨转换和代谢:一项基于人群的病例对照研究。
PLoS One. 2012;7(9):e45703. doi: 10.1371/journal.pone.0045703. Epub 2012 Sep 19.
9
Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: a consensus advice from an Austrian working group.骨质疏松症诊断与治疗中骨转换生物标志物:奥地利工作组的共识建议
Wien Med Wochenschr. 2012 Nov;162(21-22):464-77. doi: 10.1007/s10354-012-0133-9. Epub 2012 Aug 14.
10
Effects of resistance training on biomarkers of bone formation and association with red blood cell variables.抗阻训练对骨形成生物标志物的影响及其与红细胞变量的关系。
J Physiol Biochem. 2011 Sep;67(3):351-8. doi: 10.1007/s13105-011-0082-6. Epub 2011 Mar 11.